# Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

> **NCT00360308** · PHASE3 · TERMINATED · sponsor: **Eisai Limited** · enrollment: 723 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** E2007
- **DRUG:** E2007

## Key facts

- **NCT ID:** NCT00360308
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 723 (ACTUAL)
- **Why stopped:** Study stopped due to lack of efficacy.
- **Last updated:** 2014-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360308, "Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00360308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*